Compile Data Set for Download or QSAR
maximum 50k data
Found 7 Enz. Inhib. hit(s) with all data for entry = 10706
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM560830((R)-2-((1s,4S)-4-(6-fluoroquinolin-4-yl)cyclohexyl...)
Affinity DataIC50: <50nMAssay Description:The experimental principle is summarized as follows: IDO expression is low in Hela cells under no induction, but a certain concentration of IFN-γ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM560834(2-(4-(6-fluoroquinolin-4-yl)-1-hydroxycyclohexyl)-...)
Affinity DataIC50: <50nMAssay Description:The experimental principle is summarized as follows: IDO expression is low in Hela cells under no induction, but a certain concentration of IFN-γ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM560832((R)-2-((1s,4S)-4-(2-methylpyridin-4-yl)cyclohexyl)...)
Affinity DataIC50: <50nMAssay Description:The experimental principle is summarized as follows: IDO expression is low in Hela cells under no induction, but a certain concentration of IFN-γ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM560836(N-(1-((1s,4s)-4-(6-fluoroquinolin-4-yl)cyclohexyl)...)
Affinity DataIC50: <50nMAssay Description:The experimental principle is summarized as follows: IDO expression is low in Hela cells under no induction, but a certain concentration of IFN-γ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM560833((R)-N-(4-(pentafluoro-lambda6-sulfanyl)phenyl)-2-(...)
Affinity DataIC50:  125nMAssay Description:The experimental principle is summarized as follows: IDO expression is low in Hela cells under no induction, but a certain concentration of IFN-γ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM560835((R)-2-((1s,4S)-4-(6-fluoroquinolin-4-yl)cyclohexyl...)
Affinity DataIC50:  600nMAssay Description:The experimental principle is summarized as follows: IDO expression is low in Hela cells under no induction, but a certain concentration of IFN-γ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIndoleamine 2,3-dioxygenase 1(Homo sapiens (Human))
Beijing Innocare Pharma Tech

US Patent
LigandPNGBDBM560831((R)-2-((1r,4R)-4-(6-fluoroquinolin-4-yl)cyclohexyl...)
Affinity DataIC50:  600nMAssay Description:The experimental principle is summarized as follows: IDO expression is low in Hela cells under no induction, but a certain concentration of IFN-γ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent